Zum Inhalt springen
- {{#headlines}}
- {{title}} {{/headlines}}
Profil
| Derzeitige Stellung | Professor W-3 und Äquivalente |
|---|---|
| Fachgebiet | Pharmazie,Gastroenterologie |
| Keywords | Biopharmaceutic Clssification System, Bioequivalence, Prodrugs, Permeability, Targeting |
Aktuelle Kontaktadresse
| Land | USA |
|---|---|
| Ort | Ann Arbor |
| Universität/Institution | University of Michigan |
| Institut/Abteilung | College of Pharmacy |
Gastgeber*innen während der Förderung
| Prof. Dr. Peter Langguth | Institut für Pharmazie, Johannes Gutenberg-Universität Mainz, Mainz |
|---|---|
| Beginn der ersten Förderung | 01.07.2010 |
Programm(e)
| 2009 | Humboldt-Forschungspreis-Programm für Naturwissenschaftler*innen aus den USA |
|---|
Projektbeschreibung der*des Nominierenden
| Professor Gordon L. Amidon from the University of Michigan, MI, USA Professor Amidon is one of the leading experts in the pharmaceutical sciences whose contributions to basic science have had an enormous impact on academia, the pharmaceutical industry and regulatory agencies. He is recognized throughout the world for his contributions to the physical chemistry of oral drug delivery, prodrug design and his leadership role in molecular biopharmaceutics. His initialization, conceptualization and implementation of the Biopharmaceutics Classification System (BCS) made world wide impact on regulatory approaches to the development of pharmaceutical dosage forms. In Germany he will continue to establish a publicly accessible data base containing biopharmaceutical information on drugs used in therapy world wide. Professor Amidon is hosted by Professor Peter Langguth at the Johannes Gutenberg-University in Mainz |